Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,734 | -45,525 | -28,656 | -54,756 | -36,648 |
| Depreciation Amortization | 1,940 | 1,257 | 604 | 2,283 | 1,754 |
| Accounts receivable | 433 | 601 | 2,936 | N/A | -3,060 |
| Accounts payable and accrued liabilities | 1,571 | 471 | -97 | N/A | 1,576 |
| Other Working Capital | -7,654 | -7,971 | -6,472 | -12,148 | -9,272 |
| Other Operating Activity | 21,146 | 17,598 | 11,710 | 16,348 | 11,656 |
| Operating Cash Flow | $-42,298 | $-33,569 | $-19,975 | $-48,273 | $-33,994 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -114,772 | -139,768 | -114,935 | N/A | 28,970 |
| PPE Investments | -3,394 | -2,112 | -333 | -3,345 | -2,784 |
| Purchase Of Investment | -45,297 | -31,069 | -63,854 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -131 | 0 |
| Investing Cash Flow | $-163,463 | $-172,949 | $-179,122 | $-3,476 | $26,186 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 213,814 | 211,161 | 211,119 | N/A | 64 |
| Other Financing Activity | 0 | 0 | 0 | 55,615 | -1,341 |
| Financing Cash Flow | $213,814 | $211,161 | $211,119 | $55,615 | $-1,277 |
| Beginning Cash Position | 30,532 | 30,532 | 30,532 | 26,666 | 26,666 |
| End Cash Position | 38,585 | 35,175 | 42,554 | 30,532 | 17,581 |
| Net Cash Flow | $8,053 | $4,643 | $12,022 | $3,866 | $-9,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,298 | -33,569 | -19,975 | -48,273 | -33,994 |
| Capital Expenditure | -3,394 | -2,112 | -333 | N/A | -2,834 |
| Free Cash Flow | -45,692 | -35,681 | -20,308 | -48,273 | -36,828 |